SGAM
FOLD

Smith Group Asset Management’s Amicus Therapeutics FOLD Stock Holding History

Smith Group Asset Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-300
Closed -$3K – 311
2021
Q4 		$3K Hold
300
– – ﹤0.01% 353
2021
Q3 		$3K Hold
300
– – ﹤0.01% 362
2021
Q2 		$3K Hold
300
– – ﹤0.01% 353
2021
Q1 		$3K Sell
300
-13,148
-98% -$204K ﹤0.01% 317
2020
Q4 		$1.09M Buy
13,448
+4,448
+49% +$91K 0.06% 97
2020
Q3 		$127K Buy
9,000
+820
+10% +$12K 0.01% 189
2020
Q2 		$123K Sell
8,180
-100
-1% -$1.22K 0.01% 186
2020
Q1 		$77K Hold
8,280
– – ﹤0.01% 226
2019
Q4 		$81K Hold
8,280
– – ﹤0.01% 249
2019
Q3 		$66K Buy
8,280
+3,320
+67% +$36K ﹤0.01% 262
2019
Q2 		$62K Hold
4,960
– – ﹤0.01% 263
2019
Q1 		$67K Sell
4,960
-16,000
-76% -$195K ﹤0.01% 284
2018
Q4 		$201K Sell
20,960
-900
-4% -$9.89K 0.01% 242
2018
Q3 		$264K Buy
21,860
+890
+4% +$12.4K 0.01% 235
2018
Q2 		$328K Buy
20,970
+200
+1% +$3.02K 0.01% 215
2018
Q1 		$312K Sell
20,770
-10,630
-34% -$162K 0.01% 219
2017
Q4 		$452K Hold
31,400
– – 0.01% 215
2017
Q3 		$474K Hold
31,400
– – 0.02% 218
2017
Q2 		$316K Buy
+31,400
New +$253K 0.01% 241
2015
Q4 		– Sell
-105,780
Closed -$1.48M – 491
2015
Q3 		$1.48M Sell
105,780
-32,750
-24% -$514K 0.06% 156
2015
Q2 		$1.96M Buy
138,530
+2,800
+2% +$33.7K 0.07% 149
2015
Q1 		$1.48M Sell
135,730
-117,330
-46% -$1.03M 0.05% 156
2014
Q4 		$2.1M Sell
253,060
-114,310
-31% -$785K 0.07% 150
2014
Q3 		$2.19M Sell
367,370
-1,270
-0.3% -$6.65K 0.08% 154
2014
Q2 		$1.23M Buy
368,640
+101,160
+38% +$237K 0.05% 175
2014
Q1 		$554K Buy
+267,480
New +$669K 0.02% 195

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Smith Group Asset Management's FOLD Position: Q1 2022 in Review

Smith Group Asset Management sold out of Amicus Therapeutics (FOLD) in Q1 2022, closing a stake of 300 shares — an estimated $3K sold.

Smith Group Asset Management first reported a position in FOLD in Q1 2014 and held it in 26 quarters. The position peaked at $2.19M in Q3 2014. 217 funds tracked by Wall St. Rank hold FOLD as of Q1 2022.

  • Smith Group Asset Management reported no remaining Amicus Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Smith Group Asset Management sold 300 Amicus Therapeutics shares in Q1 2022, an estimated $3K.
  • Smith Group Asset Management first reported a position in Amicus Therapeutics in Q1 2014 and held it in 26 quarters.
  • Smith Group Asset Management's Amicus Therapeutics position peaked at $2.19M in Q3 2014.
  • 217 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2022.

Based on Smith Group Asset Management's 13F filing for Q1 2022, filed 5 May 2022.